Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
reduce unnecessary regulatory barriers, and help bring lower-cost prescription drugs to patients faster. Biologics are among … disorders. Because of the extensive research and development costs that are associated with these cutting-edge treatments, they